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Summary: A method was developed for the simultaneous determination of hypoxanthine, xanthine, uric acid
and allantoin based on isocratic reversed-phase chromatography. This HPLC-method additionally allows the
direct determination with UV-detection of inosine-5'-phosphate, uridine, thymine, orotic acid, allopurinol and
oxipurinol, besides hypoxanthine, xanthine and uric acid in the same Chromatographie run. Allantoin elutes
in this system near the void volume and a fraction is collected covering the retention time range for this
substance. After hydrolysis allantoin is converted to glyoxylate-2,4-dinitrophenylhydrazone, rechromato-
graphed and detected at 360 nm.
The coefficient of variation for this method does not exceed 5.0% for a serum concentration of 0.3 μηιοΙ/1
hypoxanthine and is not greater than 5.3% for a xanthine concentration of 0.3 μιηοΐ/ΐ serum. Recoveries were
90—110% for both hypoxanthine and xanthine. The determination of uric acid had an imprecision and
inaccuracy not exceeding 1.45% in the concentration range of 103 — 568 μιηοΐ/ΐ. Due to the more complex
procedure required for the determination of allantoin, the coefficient of variation between days was 13.6%
for a sample containing 0.8 μπιοΐ/l allantoin and the recoveries for this analyte were in the range of 86 — 93%.
Reference ranges (mean ± SD) determined on 171 serum samples from healthy adults were 12.7 ± 6.6 μιηοΐ/ΐ
for hypoxanthine, 3.3 ±1.4 μιηοΐ/ΐ for xanthine, and 15.7 ± 7.9 μιηοΐ/ΐ for allantoin. No significant age or
sex dependence was observed. Uric acid concentrations were 320 ± 55 μιηοΐ/l serum for men and 206 ± 55
μιηοΐ/ΐ for women.
Introduction
 0 ι * j· u u c Λ * ^Several studies have been performed to assess the
The myocytes as well as the vascular endothelial cells relevance of purine metabolism in ischemic tissue
of the heart are both targets for damage by free (2—4), but no attempt has been made to determine"
radicals generated during myocardial ischemia and the metabolites arising from the action of xanthine
reperfusion. A possibly important process for the oxido-reductase on allantoin, the product resulting
generation of oxygen radicals is the conversion of from the oxidation of uric acid by free oxygen radi-
hypoxanthine to xanthine and finally uric acid by the cals. The function of uric acid as an antioxidant in
enzyme xanthine oxido-reductase (EC 1.2.3.2) local- vitro has been shown for several targets of free radical
ized in the endothelial cell. Normally this enzyme action (5—7); furthermore, it has been shown that
reduces NAD4" and does not form free oxygen radi- the concentration of allantoin is elevated in synovia
cals, but it has been shown by McCord et al. (1), that and serum of rheumatoid patients (8).
this enzyme is converted during ischemia to the oxi-
 TT x , . . . r TmT ^ ., ,
Λ c t . ι ι Γ - Here we report the optimization of an HPLC methoddase form, which uses molecular oxygen as an όχι- , . ι · , · r i_ j · * · <-
,. . * · * j rxTA-rn- and its analytical properties for the detennination ofdizing agent instead of NAD+. J v *
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terminal metabolites of purine metabolism including
"non-physiological" allantoin. Reference ranges were
assessed for hypoxanthine, xanthine, uric acid and
allantoin.
Materials and Methods
Chemicals
Allantoin, allopurinol, hyoxanthine, inosine-5'-phosphate, or-
otic acid, oxipurinol, thymine, uridine and xanthine were ob-
tained from SIGMA, Munich, Germany in the highest available
grade of purity and used for preparation of the standard so-
lutions. Uric acid was Standard Reference Material with a
purity of 99.7% (SRM 913, National Bureau of Standards,
Washington D. C. 20234). All other chemicals were purchased
from Merck (Darmstadt, Germany) and were of analytical
grade; methanol was HPLC-grade. Demineralized water was
prepared with a Milli-Q apparatus from Millipore GmbH
(Eschborn, Germany). The control material for the uric acid
determination was Standard Reference Material (Human Serum
SRM 909, National Bureau of Standards, Washington D. C.
20234).
Samples
The serum samples for the reference range assessment were
from healthy blood donors. The Sarstedt system with separation
gel was used for withdrawn blood, and the time between blood
withdrawal and centrifugation never exceeded 30 min.
and uridine were dissolved in demineralized water. Allopurinol,
hypoxanthine, oxipurinol, thymine and xanthine were dissolved
in 0.1 mol/1 NaOH, and uric acid was dissolved in 0.013 mol/1
NH3.
Preparation of the standard mixture
for the solvent system optimization
For every pH the standard mixture was prepared from the
stock-standards separately. A solution consisting of 1 ml of
each stock-standard (total volume 11 ml) was mixed with 9 ml
solvent B to give a final volume of 20 ml. The concentrations
of each constituent in the standard mixture was 25 μιηοΐ/ΐ. An
aliquot (50 μΐ) of this standard mixture, containing 1.25 nmpl
of each component, was injected for the determination of the
retention times.
Preparation of the standards for the determination
of hypoxanthine, xanthine, uric acid and allantoin in serum
Stock-standards of hypoxanthine, xanthine and allantoin (1 ml
of each) were mixed with 20 ml of the stock-standard of uric
acid and diluted with solvent C to 50 ml in a volumetric flask.
This standard, which contained 10 μπιοΐ/l hypoxanthine, xan-
thine and allantoin and 200 μηιοΐ/ΐ uric acid, was diluted to
produce a calibration curve covering the range from 25 prnol
to 500 pmol injected hypoxanthine, xanthine and allantoin.
Uric acid was injected to produce a range between 0.5 nmol
and 100 nmol. Hypoxanthine was detected at a wavelength of
248 nm, xanthine at 264 nm, and uric acid at 285 iim. The
calibration was based on the areas calculated with the Waters
PDA-990-f photo-diode-array integration software.
High performance l iquid chromatography
The HPLC was performed on a Bruker Model LC-31 Chro-
matograph equipped with Rheodyne injection valve (100 μΐ
injection-loop), 20x4 mm RP-18 guard-column, 250 χ 4mm
RP-18 analytical colum, both packed with LiChrosorb RP-18,
5 μπι material from Merck (Darmstadt, Germany). The guard
column had to be replaced every 30 injections to avoid signif-
icant reduction of the separation properties.
UV-detection was performed with a photo-diode-array-detector
(Millipore-Waters PDA-990+) using the following settings:
wavelength range 200—400 nm, resolution 2nm, 1 scan per
second, 27 ms sampling time; 27 sampling times were averaged
per scan; sensitivity was set to high (7 points).
The eluents used were:
Solvent A: demineralized water
Solvent B: K2HPO4/KH2PO4/H3PO4-buffer with 100
mmol/1 phosphate, pH ranging from 2.50 to
7.50
Solvent C: KH2PO4/H3PO4-buffer with 50 mmol/1 phos-
phate, pH 4.60
Solvent D: tri-sodium-citrate 30 mmol/1, sodium-acetate
27.7 mmol/1, pH 4.75, methanol, volume frac-
tion 0.25
The flow-rate was 1 ml/min, corresponding to a back-pressure
of 130-145 bar.
Procedures and measurements
Preparation of the stock-standards
The final standard concentration for all substances was 500
μηιοΐ/ΐ. Allantoin, creatinine, inosine-S'-phosphate, orotic acid
Preparation of the serum samples
A serum sample (100 μΐ) was mixed with 400 μΐ of solvent C,
then filtered through a membrane filter with a pore diameter
of 0.22 μπι (Millipore GmbH, Eschborn, Germany). An aliquot
(50 μΐ) of the filtrate was directly injected into the rheodyne
injector of the HPLC device. The quantification of hypoxan-
thine, xanthine and uric acid is based on the peak areas calr
culated for the wavelength described in the previous section.
Determination of allantoin
Allantoin was determined with a method according to Grootveld
(8) with minor modifications. Serum samples and standards
were treated in the same way. The fraction between elution
time to of the void volume and to + 2 min was collected and
evaporated under a nitrogen stream at 60 °C. The residue was
reconstituted in 250 μΐ 0.12 mol/1 NaOH and incubated for 20
min at 100 °C. In this step allantoin is hydrolysed to allantoic
acid. After adding 250 μΐ l mol/1 HC1 the mixture was incubated
for 5 min at 100 0C. This step hydrolyses allantoic to giyoxylic
acid. Finally 25 μΐ 3 mmol/1 2,4-dinitrophenylhydraziniumhy-
drochloride in l mol/1 HC1 was added and the mixture incu-
bated for 5 min at 100 °C. To enhance the precision of the
determination, the final incubation mixture was evaporated to
dryness under a nitrogen stream at 60 °C The residue was
dissolved in 250 μΐ solvent D and 50 μΐ were injected into the
HPLC-apparatus for isocratic rechromatography with solvent
D, using the same column as before. The detection was per-
formed at a wavelength of 360 nm.
Solvent system optimization
The eluent optimization was performed for pH values between
2.50 and 7.50 and for phosphate ion concentrations between
20 mmol/1 and 100 mmol/i. At every pH the retention times of
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the components allantoin, allopurinol, creatinine, hypoxan-
thine, inosine-5'-phosphate, orotic acid, oxipurinol, thymine,
uridine, xanthine, uric acid were measured five times.
For calculation of the optimized eluent Composition the treat-
ment described by Glajch (1980) was used. The chromalo-
graphic-response-function (CRF) has the general form:
CRF = Σ In (Pj/Po) + α ft» - tL) (Eq. 1)
where
Pi = f/g is a measure of resolution of a pair of adjacent peaks;
f is the vertical distance of the valley-point between the two
peaks and the line connecting the two peak maxima;
g is the vertical distance of the baseline to the line connecting
the two peaks. If there is baseline-separation, f is equal to g
and this results in Pj = 1 or In pi,· = 0;
PO is the desired peak separation and it is taken as 1 in this
solvent system optimization.
The second expression contains
tM, the maximum acceptable analysis time for one Chromato-
graphie run;
tL, the actual analysis time and
a, an arbitrary weighting factor.
For simplification of the calculation presented here, the second
expression is ignored. Only the separation of uric acid at a
wavelength of 285 nm, hypoxanthine at 248 nm and xanthine
at 264 nm from their adjacent peaks is of interest and needs to
be considered. The function CRF defined in this way has an
absolute extremum of CRF = 0 only when all substances of
interest are baseline-separated from their neighbouring peaks.
It is necessary to find one local extremum describing the solvent
composition for the best separation of hypoxanthine, xanthine
and uric acid from their neighbouring peaks.
The function CRF is then plotted as a function of pH and
phosphate concentration c. The two variables of the elution
system and the hyperplane should be described by a polynomial
dependence of CRF (called z) on pH (called x) and c (called x):
Σ xn~k yk (Eq.2)
The results found for the Chromatographie response function
have to be fitted according to equation 2 with a method for a
constrained multidimensional nonlinear-least-square fit (10) us-
ing the constraint z g 0. Finally the result for the pH and the
phosphate concentration yielding the best separation is found
from the total differential of CRF, as the highest local maximum
of this function in the range 2.5 ^ pH < 7.5 and 20 mmol/l
<, c < 100 mmol/l.
Results
Solvent optimization for the determination
of uric acid, hypoxanthine, xanthine
and allantoin
The results for the determination of the Chromato-
graphie response function for the separation of uric
acid, hypoxanthine and xanthine from the neigh-
bouring peaks are shown in figure 1. The optimization
converged and the local maximum of the function
2 3 '4
— t
5
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1 1100
Fig. 1. Results for the calculation of the Chromatographie re-
sponse function (CRF) in dependence on the p H and
the total phosphate ion concentration of the eluent. The
filled circle with the falling line on the plane of the
independent variable indicates the solvent composition
determined with the procedure described in methods.
The optimized solvent composition was p H 4.65 and 47
mmol/l total phosphate ion concentration. The obtained
Chromatographie response function was CRF = —0.36.
CRF was found at a solvent pH of 4.65 and a phos-
phate ion concentration of 47 mmol/l. The calculated
value at this eluent composition was CRF = —0.36.
All following data were obtained with this eluent
system and the CRF calculated from a chromatogram
of a standard mixture (fig. 2) was CRF = -0.39
+ 0.02 (x + s). Due to the tailing of the peaks a full
baseline separation could not be obtained with this
Chromatographie system, but due to the relative con-
centrations of uric acid, hypoxanthine, uridine, and
xanthine in serum this was satisfactory for all serum
samples analysed. A chromatogram of a serum sample
drawn from a healthy male adult is shown in figure 3.
Imprecision data for the determination
of hypoxanthine and xanthine
Table 1 shows the data for the within-run imprecisions
and the day-to-day imprecisions for serum samples
supplemented with hypoxanthine and xanthine stan-
dard to cover the measuring range of interest. For
these measurements, 50 μΐ aliquots of fivefold dilu-
tions of the standard-substituted pooled serum sam-
ples were injected. The lowest concentration of 0.3
μηιοΙ/1 hypoxanthine and xanthine corresponds to the
itijection of 3 pmol analyte. Within-run imprecision
for the concentration range considered was 1.9% —
4.5% for hypoxanthine and 1.5%-4.7% for xan-
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Fig. 2. Multiwavelength chroraatogram of a standard mixture
performed at 248 nm, 264 nm and 285 nm. The standard
contained 45 μιηοΐ/ΐ of each substance. The eluent was
the optimized phosphate buffer with 47 mmol/l phos-
phate and pH 4.65.
Peak identification:
1. orotic acid
2. inosine-5'-phosphate
3. uric acid
4. hypoxanthine
5. uridine
6. xanthine
7. thymine
8. oxipurinol
9. allopurinol
Fig. 3. Multiwavelength chromatogram of a normal serum
sample with 208 μπιοΙ/1 uric acid (peak 1), 3.1 μιηοΐ/ΐ
hypoxanthine (peak 2), uridine (peak 3) and 0.56 μιήοΐ/ΐ
xanthine (peak 4), performed at 248 nm, 264 nm and
285 nm. The eluent was the optimized phosphate buffer
with 47 mmol/l phosphate and pH 4.65.
thine. Due to the error introduced from the calibra-
tion, the day-to-day imprecision was 2.2 — 5.0% for
hypoxanthine and 2.7% —5.3% for xanthine.
Tab. 1. Imprecision data for the determination of hypoxanthine, xanthine and uric acid
Analyte Imprecision within-run (n = 20) Imprecision day-to-day (n = 20)
Mean concentration
[μιηοΐ/ΐ]
Coefficient of variation Mean concentration
[μιηοΐ/ΐ]
cv
Hypoxanthine
Xanthine
Uric acid
27.6
5.5
1.1
0.3
26.9
6.1
1.2
0.3
510
366
189
123
1,9
2.3
3.1
4.5
1.5
2.0
2.9
4.7
1.11 '
0.95
1.34
1.18
25.3
4.8
1.0
0.3
27.2
1.2
1.4
0.3
568
331
219
103
2.2
3.1
3.9
5.0
2.7
2.9
4.6
5.3
1.37
1.31
1.23
1.45
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Tab. 2. Recoveries of hypoxanthine and xanthine (n = 20)
Analyte Added concentration
fomol/l]
Mean recovery Standard deviation
of recovery [%]
Hypoxanthine
Xanthine
20.3
4.1
1.0
0.2
20.5
4.1
1.0
0.2
101.2
94.3
95.8
90.2
97.9
90.8
108.4
107.3
2.8
3.2
4.6
5.4
2.4
2.9
3.8
4.9
Recovery data for hypoxanthine
and xanth ine
Table 2 shows the standard recoveries for hypoxan-
thine and xanthine. For these experiments 200 μΐ
pooled serum, 200 μΐ standard of the concentration
shown in table 2 and 600 μΐ eluent were mixed, and
50 μΐ of this dilution were injected. In the case of
hypoxanthine recoveries ranged from 90.2% to
101.2% with standard deviations not different from
the imprecisions found. For xanthine the situation is
similar to that of hypoxanthine, with recoveries rang-
ing from 97.9% to 107.3%.
Imprecision and inaccuracy of the uric acid
determination
The imprecision of the uric acid determination was
determined separately from 4 pooled serum samples
(data shown in tab. 1); the within-run imprecision was
0.95%-1.34%, between-run 1.23%-1.45%. The in-
accuracy, determined with the reference material, hu-
man serum SRM 909 (certified uric acid concentration
480 μπιοΙ/1), was 485 ± 6 μιηοΐ/ΐ (η = 20).
CO
CO
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0.10
0.05
0.00
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Retention time [min]
12.5 15.0
Fig. 4. Chromatogram (with detection at 360 nm) of the gly-
oxylate-2,4-dinitrophenylhydrazone, derived from the
serum sample shown in figure 3, which contained 20
μηιοΐ/ΐ allantoin.
Tab. 3. Imprecision within-run, imprecision day-to-day and recoveries for the determination of aliantoin
Imprecision within-run (n = 20) Imprecision day-to-day (n = 20)
Mean concentration
[μιηοΐ/ΐ]
Coefficient of variation Mean concentration
Qimol/l]
Coefficient of variation
32.3
16.4
3.1
0.5
5.8
6.9
9.2
11.7
42.4
11.3
5.2
0.8
6.3
8.1
11.6
13.6
Standard recoveries (n = 20)
Added concentration
[μπιοΙ/1]
Mean recovery Standard deviation of recovery
36.4
8.5
3.1
0.$
86.3
82.7
90.1
93.2
7.0
8.9
10.2
14.4
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Imprecision and recovery
for the determination of allantoin
Table 3 shows the data for the imprecision and re-
covery experiments for allantoin. Figure 4 shows the
chromatogram of the glyoxylate-2,4-dinitrophenylhy-
drazone from a serum sample containing 20 μπιοΐ/ΐ
allantoin. Pooled serum was substituted with an al-
lantoin standard solution and diluted with eluent C
to give a five-fold serum dilution; 50 μΐ of this dilution
were subsequently analysed. The imprecision was
5.8%-11.7% within-run and 6.3%-13.6% day-to-
day. The recoveries, determined in samples treated as
described for hypoxanthine and xanthine, were 86.3%
to 93.2%.
• r
Reference ranges
Table 4a shows the results for the reference ranges
determined for hypoxanthine, xanthine, allantoin,
table 4b the results for uric acid, and figure 5a—5d
the corresponding reference-ranges for all women in
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Fig. 5a—d. The reference range of serum of
a) hypoxanthine
b) xanthine,
c) uric acid and
d) allantoin
for 11 adult males and 94 adult females. For age-and sex-dependence of the reference ran^e for uric acid see table
Reference range adult females
Reference range adult males
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comparison with all men. No significant age or sex
dependence was found for hypoxanthine, xanthine
and aliantoin based on a distribution comparison by
means of a non-parametric two-sided Komolgoroff-
Smirnoff-test with a 5%-significance level. Only uric
acid shows differences between males and females and
an age dependence in males.
Discussion
Optimization of the Chromatographie procedure
showed that the best separation between the serum
constituents inosine-5'-phosphate, uric acid, hypoxan-
thine, uridine and xanthine could be obtained with a
potassium dihydrogenphosphate buffer with a pH of
4.60 and a phosphate concentration of 50 mmol/1.
Tab. 4a. Reference — ranges for hypoxanthine, xanthine and
aliantoin in serum
Hypoxanthine [μιηοΐ/ΐ].
Xanthine [μιηοΐ/ΐ]
Aliantoin [μπιοΐ/ΐ]
Mean
12.7
3.3
15.7
Standard
diviation
6.6
1.4
7.9
Range
1.2-17.9
0.2- 5.8
3.1^-36.4
For this solvent system one Chromatographie run
takes 20 min and a sufficient separation is established
for all compounds in the serum samples tested. Due
to the dynamic measuring range of the photo-diode-
array-detector, uric acid could be quantified from the
same Chromatographie run as hypoxanthine and xan-
thine, whose concentrations are about 30 and 150
times lower, respectively. Neither normal sera nor
pathological sera from patients caused any observable
Chromatographie interference. The use of a guard
column in the method presented eliminates the re-
quirement for sample deproteinisation techniques like
ultrafiltration or protein precipitation with for ex-
ample trichloroacetic acid. In contrast to the proce-
dure originally presented by Grootveld (8), the deter-
mination of aliantoin presented here is not sensitive
to unintentional evaporation of the incubation mix-
ture, because the glyoxylic acid-2,4-dinitrophenylhy-
drazone is finally dried and reconstituted in a well
defined volume of solvent.
For hypoxanthine a coefficient of variation between
days (CVdd) of 5.0% was found for an injection of
3 pmol substance. For 3 pmol injected xanthine a
slightly higher CVdd of 5.3% was found; this is due
to a broader elution band shape. The recoveries in
the standard recovery experiments were 90 — 110%,
determined by means of standard additions covering
the reference range. The much more complicated de-
Tab. 4b. Reference range for uric acid in serum
a) Men
Age
[a]
10-20
21-30
31-40
41-50
51-60
>60
all
η
32
19
14
12
12
5
94
Concentration
mean
288
321
305
346
378
361
320
of uric acid [μιηοΐ/ΐ]
standard deviation
25
36
31
47
35
27
55
range
207-369
231-398
256-407
216-442
265-403
281-417
207-442
b) Women
Age
[a]
10-20
21-30
31-40
41-50
51-60
>60
all
η
21
14
12
10
12
8
77
Concentration
mean
207
178
213
231
180
250
206
of uric acid [μπιοί/]
standard deviation
25
34
31
26
40
62
61
range
162-314
151-279
167-296
181-343
224-297
211-367
151-367
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termination procedure for allantoin resulted in a CVdd
of 13.6% when analysing a 8 pmol sample, and the
recoveries found for allantoin were 86 — 93%. The
results for uric acid were comparable to those previ-
ously published for a HPLC procedure optimized for
the determination of uric acid.
The reference ranges of hypoxanthine, xanthine and
allantoin did not show a significant dependence on
age or sex. Only uric acid showed the well established
higher reference range for men and an increase of this
reference range for men with age.
With the method presented, a sensitive simultaneous
determination of the metabolites of terminal purine
metabolism, hypoxanthine, xanthine, uric acid and
allantoin is possible. The method may also be used
for other body fluids like urine and cerebrospinal
fluid.
A paper is in preparation, in which we describe the
changes of hypoxanthine, xanthine, uric acid and
allantoin in patients with clincally well defined acute
myocardial infarction in comparison with other dis-
eases with muscle destruction.
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